These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18215777)

  • 1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
    Oliansky DM; Appelbaum F; Cassileth PA; Keating A; Kerr J; Nieto Y; Stewart S; Stone RM; Tallman MS; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):137-80. PubMed ID: 18215777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
    Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):823-61. PubMed ID: 16275588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
    Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):1-30. PubMed ID: 16399566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
    Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
    Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
    Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
    Hamadani M; Awan FT; Copelan EA
    Biol Blood Marrow Transplant; 2008 May; 14(5):556-67. PubMed ID: 18410898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Lekakis L; de Lima M
    Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.
    Oliansky DM; Larson RA; Weisdorf D; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):18-36.e6. PubMed ID: 21803017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia.
    Hamadani M; Awan FT
    Hematol Oncol; 2010 Mar; 28(1):3-12. PubMed ID: 19645073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
    Craddock CF
    Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults.
    Asbmt Position Statement
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):135-6. PubMed ID: 18215776
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
    Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Place of HSCT in treatment of childhood AML.
    Klingebiel T; Reinhardt D; Bader P;
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S7-9. PubMed ID: 18978749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).
    Appelbaum FR
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):85-92. PubMed ID: 18342816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.